色又黄又爽18禁免费网站现观看,无码人妻一区二区三区兔费,国产精品久久国产精无码懂色,欧美日韩国产二区

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質(zhì)量反饋  人才招聘  關于我們  聯(lián)系我們
產(chǎn)品中心-北京博奧森生物技術有限公司
首頁 > 產(chǎn)品中心 > 試劑盒 > 產(chǎn)品信息
Mouse Erythropoietin ELISA Kit (bsk12081)  
訂購熱線:400-901-9800
訂購郵箱:sales@bioss.com.cn
訂購QQ:  400-901-9800
技術支持:techsupport@bioss.com.cn
說明書: 96T  
96T/2900.00元
大包裝/詢價
產(chǎn)品編號 bsk12081
英文名稱 Mouse Erythropoietin ELISA Kit
中文名稱 小鼠促紅細胞生成素酶聯(lián)免疫試劑盒
別    名 EPO, EP, MVCD2, erythropoietin, Erythropoietin   
種    屬 Mouse
線性范圍 62.5 - 4000 pg/mL
應用范圍 S/P/CC
檢測限 32 pg/mL
適用樣品基質(zhì) cell culture supernates, serum, and plasma.
保存條件 Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Shipped with wet ice.).
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Erythropoietin,also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.Exogenous erythropoietin can be provided to people whose kidneys cannot make enough. Recombinant human erythropoietin (rhEPO) is produced by recombinant DNA technology in cell culture. Several different pharmaceutical agents are available with a variety of glycosylation patterns and are collectively called erythropoiesis-stimulating agents (ESA). Major examples are epoetin alfa and epoetin beta. The specific details for labeled use vary between the package inserts, but ESAs have been used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Boxed warnings include a risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence.rhEPO has been used illicitly as a performance-enhancing drug;it can often be detected in blood, due to slight differences from the endogenous protein, for example, in features of posttranslational modification.

版權所有 2004-2026 www.bklrv.cn 北京博奧森生物技術有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號